http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100524329-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 1997-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100524329-B1 |
titleOfInvention | Naphthyridine Derivatives |
abstract | The novel 8-aryl-1,7-naphthyridine in free or salt form is a PDE IV inhibitor and is therefore useful as a medicament, such as for asthma treatment. Preferred compounds include those of Formulas I and IIn n n <Formula I>n n n n n n n n <Formula II>n n n n n n n n R group in the above formula is as defined. Pharmaceutical compositions comprising the compounds, methods for preparing the compounds, and novel intermediates used therein are disclosed. |
priorityDate | 1996-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 304.